Nitrous Oxide Analgesia Vaso-occlusive Crisis

Patients who have sickle cell VOC are usually treated with opioids, such as morphine.
However, this current way of treating them has not improved the health, medical outcomes, or
rates of hospitalizations. In addition, since VOC can happen very frequently over a long
period of time, giving opioids over and over again can cause both short-term and long-term
problems. Nitrous oxide (N2O) is a way of treating pain that may provide a better alternative
to repeatedly giving opioids over long periods of time. N2O has been shown to provide up to 3
hours of pain relief in inpatient patients with VOC whose pain did not improve with morphine
infusions, and is used extensively in France, where almost half of 85 pediatric emergency
departments use nitrous oxide to treat children with VOC whose pain did not get better with
standard treatment with morphine. However, pain relief which N2O provides in the acute
setting has not been well described. Therefore, the purpose of our study is to describe how
well N2O can relieve the pain in patients with SCD who present to the emergency department
and are experiencing a VOC.